|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/58 | |
| A61K 31/57 | |||
| C07J 43/00 | |||
| A61P 23/00 | |||
| A61P 25/08 |
| (11) | Number of the document | 3035940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14837132.1 |
| Date of filing the European patent application | 2014-08-22 | |
| (97) | Date of publication of the European application | 2016-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/052417 |
| Date | 2014-08-22 |
| (87) | Number | WO 2015/027227 |
| Date | 2015-02-26 |
| (30) | Number | Date | Country code |
| 201361869440 P | 2013-08-23 | US | |
| 201361869446 P | 2013-08-23 | US | |
| 201462014018 P | 2014-06-18 | US |
| (72) |
MARTINEZ BOTELLA, Gabriel, US
HARRISON, Boyd, L., US
ROBICHAUD, Albert, Jean, US
SALITURO, Francesco, Gerald, US
HERR, Robert, Jason, US
KARGBO, Robert, Borbo, US
|
| (73) |
Sage Therapeutics, Inc.,
215 First Street, Cambridge, MA 02142,
US
|
| (54) | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF |
| NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF |